Different methods for administering 17β-estradiol to ovariectomized rats result in opposite effects on ischemic brain damage

[1] Stegmayr B(1997)Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project. An ecological study of 18 populations Stroke 28 1367-1374

[2] Asplund K(1998)Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study Am J Epidemiol 147 259-268

[3] Kuulasmaa K(2001)Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study Stroke 32 2735-2740

[4] Rajakangas AM(1993)Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden Arch Intern Med 153 1201-1209

[5] Thorvaldsen P(1988)Postmenopausal oestrogen treatment and stroke: a prospective study Bmj 297 519-522

[6] Tuomilehto J(1998)Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group Jama 280 605-613

[7] Sacco RL(2001)Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS) Circulation 103 638-642

[8] Boden-Albala B(2001)A clinical trial of estrogen-replacement therapy after ischemic stroke N Engl J Med 345 1243-1249

[9] Gan R(2002)Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial Jama 288 321-333

[10] Chen X(1997)Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat J Neurosurg 87 724-730

[1] Stegmayr B(1997)Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project. An ecological study of 18 populations Stroke 28 1367-1374

[2] Asplund K(1998)Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study Am J Epidemiol 147 259-268

[3] Kuulasmaa K(2001)Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study Stroke 32 2735-2740

[4] Rajakangas AM(1993)Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden Arch Intern Med 153 1201-1209

[5] Thorvaldsen P(1988)Postmenopausal oestrogen treatment and stroke: a prospective study Bmj 297 519-522

[6] Tuomilehto J(1998)Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group Jama 280 605-613

[7] Sacco RL(2001)Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS) Circulation 103 638-642

[8] Boden-Albala B(2001)A clinical trial of estrogen-replacement therapy after ischemic stroke N Engl J Med 345 1243-1249

[9] Gan R(2002)Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial Jama 288 321-333

[10] Chen X(1997)Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat J Neurosurg 87 724-730